Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the efficacy of ertapenem and piperacillin/tazobactam with
respect to the clinical response in baseline microbiologically evaluable patients; and to
evaluate the tolerability and safety of ertapenem compared to piperacillin/tazobactam.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ertapenem Penicillanic Acid Piperacillin Piperacillin, tazobactam drug combination Tazobactam